Scholarlink

Background <p>Hyperglycaemia in pregnancy (HIP), encompassing gestational diabetes mellitus (GDM) and diabetes in pregnancy (DIP), is increasingly recognized as an early marker in the life-course trajectory of noncommunicable diseases (NCDs). In developing countries such as India, a substantial proportion of women enter pregnancy with preexisting metabolic risk factors, limiting the preventive impact of antenatal-only screening strategies.</p> Objectives <p>To propose an India-specific framework for prevention of HIP through preconceptional metabolic optimization, aligned with the life-course approach endorsed by the International Federation of Gynaecology and Obstetrics (FIGO) and supported by FOGSI.</p> Methods <p>This position statement synthesizes global evidence, epidemiological data and DIPSI experience to develop a pragmatic framework for preconceptional screening, risk stratification and intervention using both globally accepted diagnostic standards and context-specific approaches.</p> Results <p>DIPSI recommends opportunistic preconceptional screening using standard diagnostic criteria for nonpregnant adults, including fasting 75&#xa0;g OGTT and HbA1c, while permitting nonfasting glucose testing for initial risk identification in resource-constrained settings. Women are stratified into normoglycaemia, prediabetes and pregestational diabetes. Core interventions include lifestyle modification, micronutrient optimization, pharmacological management where indicated and family- and couple-centric counselling. Selective use of self-monitoring and continuous glucose monitoring is recommended. Integration into existing health systems with differentiated urban and rural strategies is emphasized.</p> Conclusion <p>Preconceptional care represents the earliest, most effective and most equitable opportunity to prevent GDM and future NCDs. A simplified, scalable, woman- and family-centred approach can interrupt the intergenerational cycle of metabolic disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preconceptional care for prevention of hyperglycaemia in pregnancy and future noncommunicable diseases: DIPSI position statement 2026 aligned with FIGO and FOGSI

  • 期刊论文

  • 发表日期：

    2026年7月18日

查看全文
  • V. Seshiah,
  • V. Balaji,
  • Rajeev Chawla,
  • David Simmons,
  • Shalini Jaggi,
  • N. Bhavatharini,
  • Sunil Gupta,
  • Anuj Maheshwari,
  • Pikee Saxena,
  • GVijay Kumar,
  • A. Shanmugam,
  • Hema Divakar,
  • A. Das,
  • Banshi Saboo,
  • Shashank Joshi,
  • Anjalakshi Chandrasekar,
  • APanneer Selvam,
  • Rutul Gokalani,
  • Rakesh Sahay,
  • Uday Thanawala,
  • Usha Sriram,
  • P. V. Rao,
  • Purvi Chawla,
  • Samar Banerjee,
  • Bharti Kalra,
  • Rajesh Jain,
  • Dhruvi Hasnani,
  • Vipul Chavda

摘要

Background

Hyperglycaemia in pregnancy (HIP), encompassing gestational diabetes mellitus (GDM) and diabetes in pregnancy (DIP), is increasingly recognized as an early marker in the life-course trajectory of noncommunicable diseases (NCDs). In developing countries such as India, a substantial proportion of women enter pregnancy with preexisting metabolic risk factors, limiting the preventive impact of antenatal-only screening strategies.

Objectives

To propose an India-specific framework for prevention of HIP through preconceptional metabolic optimization, aligned with the life-course approach endorsed by the International Federation of Gynaecology and Obstetrics (FIGO) and supported by FOGSI.

Methods

This position statement synthesizes global evidence, epidemiological data and DIPSI experience to develop a pragmatic framework for preconceptional screening, risk stratification and intervention using both globally accepted diagnostic standards and context-specific approaches.

Results

DIPSI recommends opportunistic preconceptional screening using standard diagnostic criteria for nonpregnant adults, including fasting 75 g OGTT and HbA1c, while permitting nonfasting glucose testing for initial risk identification in resource-constrained settings. Women are stratified into normoglycaemia, prediabetes and pregestational diabetes. Core interventions include lifestyle modification, micronutrient optimization, pharmacological management where indicated and family- and couple-centric counselling. Selective use of self-monitoring and continuous glucose monitoring is recommended. Integration into existing health systems with differentiated urban and rural strategies is emphasized.

Conclusion

Preconceptional care represents the earliest, most effective and most equitable opportunity to prevent GDM and future NCDs. A simplified, scalable, woman- and family-centred approach can interrupt the intergenerational cycle of metabolic disease.